Mouche Isabelle, Malésic Laure, Gillardeaux Olivier
GenEvolutioN, 4, Rue des frères Montgolfier, Rosny-sur-Seine, 78710, France.
, Paris, France.
Methods Mol Biol. 2017;1641:311-324. doi: 10.1007/978-1-4939-7172-5_17.
The frog embryo teratogenesis assay Xenopus (FETAX) test is a development toxicity screening test. Due to the small amount of compound needed and the capability to study organogenesis in a short period of time (96 h), FETAX test constitutes an efficient development toxicity alert test when performed early in drug safety development. The test is conducted on fertilized Xenopus laevis mid-blastula-stage eggs over the organogenesis period. Compound teratogenic potential is determined after analysis of the mortality and malformation observations on larvae. In parallel, FETAX test provides also information concerning embryotoxic effect based on larva length.
非洲爪蟾胚胎致畸试验(FETAX)是一种发育毒性筛选试验。由于所需化合物量少,且能够在短时间内(96小时)研究器官发生过程,FETAX试验在药物安全性研发早期进行时,构成了一种有效的发育毒性预警试验。该试验在非洲爪蟾中囊胚期受精卵的器官发生期进行。在分析幼虫的死亡率和畸形情况后,确定化合物的致畸潜力。同时,FETAX试验还基于幼虫长度提供有关胚胎毒性作用的信息。